Speaker
Summary
In recent years, the scientific community has shed light on innovative radionuclides that hold great promise for the so-called “precision medicine”. Among them, radiometals with theranostic/therapy properties are gaining attention because they can be used to label molecules better suited to specific pathologies. The most desired radiometals are typically produced using the direct activation method, which involves cyclotron irradiation of a solid target. To this end, the SPES cyclotron at INFN-LNL may represent a resource for the advancement of research in this field. The manufacturing of solid targets is a complex process that relies on many aspects, covering different areas of knowledge. Thus, research and development activities on solid target manufacturing technology are crucial to ensuring a reasonable supply of radionuclides with the requested radionuclide/radiochemical purity.
| Are you interested/eligible for the Young Session? | Yes, I am eligible and interested in participating |
|---|
